Why is Hester Bios falling/rising?

As of 15-Sep, Hester Biosciences Ltd is experiencing a decline in its stock price, currently at 2,055.00, reflecting a decrease of 17.0 points or 0.82%. The stock has underperformed its sector today by 0.37% and has been on a consecutive downward trend for the last two days, resulting in a total decline of 2.65%. Over the past week, the stock has fallen by 3.37%, while its performance over the past year shows a significant drop of 15.08%. Despite positive financial results, including a 145.1% growth in net profit and consistent positive results over the last five quarters, the stock's high Debt to EBITDA ratio of 3.49 times and low return on capital employed indicate underlying financial pressures that may be contributing to its recent price movement.
In the broader market context, the Sensex has shown a positive return of 1.24% over the past week, contrasting sharply with Hester Bios' decline. This suggests that while the overall market is performing well, Hester Bios is struggling to keep pace, evidenced by its significant underperformance over the past year compared to the market's negative return of only 3.45%. The lack of domestic mutual fund investment, which stands at 0%, may also reflect a lack of confidence in the stock's valuation and future growth potential, further exacerbating its price decline.